BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Eyileten C, Wicik Z, De Rosa S, Mirowska-Guzel D, Soplinska A, Indolfi C, Jastrzebska-Kurkowska I, Czlonkowska A, Postula M. MicroRNAs as Diagnostic and Prognostic Biomarkers in Ischemic Stroke-A Comprehensive Review and Bioinformatic Analysis. Cells 2018;7:E249. [PMID: 30563269 DOI: 10.3390/cells7120249] [Cited by in Crossref: 71] [Cited by in F6Publishing: 78] [Article Influence: 17.8] [Reference Citation Analysis]
Number Citing Articles
1 Ma H, Fu M, Masula M, Xing C, Zhou Q, Tan J, Wang J. miR-3064-5p and miR-4745-5p affect heparin sensitivity in patients undergoing cardiac surgery by regulating AT-III and factor X mRNA levels. Front Physiol 2022;13:914333. [DOI: 10.3389/fphys.2022.914333] [Reference Citation Analysis]
2 Wang Y, Jin X, Fan Q, Li C, Zhang M, Wang Y, Wu Q, Li J, Liu X, Wang S, Wang Y, Li L, Ling J, Li C, Wang Q, Liu Y. Deciphering the Active Compounds and Mechanisms of HSBDF for Treating ALI via Integrating Chemical Bioinformatics Analysis. Front Pharmacol 2022;13:879268. [PMID: 35721141 DOI: 10.3389/fphar.2022.879268] [Reference Citation Analysis]
3 Cullell N, Soriano-Tárraga C, Gallego-Fábrega C, Cárcel-Márquez J, Torres-Águila NP, Muiño E, Lledós M, Llucià-Carol L, Esteller M, Castro de Moura M, Montaner J, Fernández-Sanlés A, Elosua R, Delgado P, Martí-Fábregas J, Krupinski J, Roquer J, Jiménez-Conde J, Fernández-Cadenas I. DNA Methylation and Ischemic Stroke Risk: An Epigenome-Wide Association Study. Thromb Haemost 2022. [PMID: 35717949 DOI: 10.1055/s-0042-1749328] [Reference Citation Analysis]
4 Zu J, Zuo L, Zhang L, Wang Z, Shi Y, Gu L, Zhang Z. Circular RNA FUNDC1 for Prediction of Acute Phase Outcome and Long-Term Survival of Acute Ischemic Stroke. Front Neurol 2022;13:846198. [DOI: 10.3389/fneur.2022.846198] [Reference Citation Analysis]
5 Ciarambino T, Crispino P, Mastrolorenzo E, Viceconti A, Giordano M. Stroke and Etiopathogenesis: What Is Known? Genes 2022;13:978. [DOI: 10.3390/genes13060978] [Reference Citation Analysis]
6 Zhou X, Xu C, Chao D, Chen Z, Li S, Shi M, Pei Y, Dai Y, Ji J, Ji Y, Ji Q. Acute Cerebral Ischemia Increases a Set of Brain-Specific miRNAs in Serum Small Extracellular Vesicles. Front Mol Neurosci 2022;15:874903. [DOI: 10.3389/fnmol.2022.874903] [Reference Citation Analysis]
7 Eyileten C, Jakubik D, Shahzadi A, Gasecka A, van der Pol E, De Rosa S, Siwik D, Gajewska M, Mirowska-Guzel D, Kurkowska-Jastrzebska I, Czlonkowska A, Postula M. Diagnostic Performance of Circulating miRNAs and Extracellular Vesicles in Acute Ischemic Stroke. Int J Mol Sci 2022;23:4530. [PMID: 35562921 DOI: 10.3390/ijms23094530] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Zhao J, Wang Q, Zhu R, Yang J. Circulating Non-coding RNAs as Potential Biomarkers for Ischemic Stroke: A Systematic Review. J Mol Neurosci. [DOI: 10.1007/s12031-022-01991-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Wang H, Yang H, Chang M, Sun F, Qi H, Li X. Long non-coding RNA TTTY15 sponges miR-520a-3p to exacerbate neural apoptosis induced by cerebral ischemia/reperfusion via targeting IRF9 in vivo and in vitro. Biomedical Journal 2022. [DOI: 10.1016/j.bj.2022.04.001] [Reference Citation Analysis]
10 Sun P, Hamblin MH, Yin K. Non-coding RNAs in the regulation of blood–brain barrier functions in central nervous system disorders. Fluids Barriers CNS 2022;19. [DOI: 10.1186/s12987-022-00317-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Wicik Z, Czajka P, Eyileten C, Fitas A, Wolska M, Jakubik D, von Lewinski D, Sourij H, Siller-matula JM, Postula M. The role of miRNAs in regulation of platelet activity and related diseases - a bioinformatic analysis. Platelets. [DOI: 10.1080/09537104.2022.2042233] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
12 Zhao X, Liu J, Yang L, Niu Y, Ren R, Su C, Wang Y, Chen J, Ma X. Beneficial effects of mijianchangpu decoction on ischemic stroke through components accessing to the brain based on network pharmacology. J Ethnopharmacol 2022;285:114882. [PMID: 34848358 DOI: 10.1016/j.jep.2021.114882] [Reference Citation Analysis]
13 Eyileten C, Wicik Z, Fitas A, Marszalek M, Simon JE, De Rosa S, Wiecha S, Palatini J, Postula M, Malek LA. Altered Circulating MicroRNA Profiles After Endurance Training: A Cohort Study of Ultramarathon Runners. Front Physiol 2022;12:792931. [DOI: 10.3389/fphys.2021.792931] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
14 Shawki SM, Saad MA, Rahmo RM, Wadie W, El-Abhar HS. Liraglutide Improves Cognitive and Neuronal Function in 3-NP Rat Model of Huntington's Disease. Front Pharmacol 2021;12:731483. [PMID: 35002691 DOI: 10.3389/fphar.2021.731483] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
15 Eyileten C, Wicik Z, Simões SN, Martins-Jr DC, Klos K, Wlodarczyk W, Assinger A, Soldacki D, Chcialowski A, Siller-Matula JM, Postula M. Thrombosis-related circulating miR-16-5p is associated with disease severity in patients hospitalised for COVID-19. RNA Biol 2022;19:963-79. [PMID: 35938548 DOI: 10.1080/15476286.2022.2100629] [Reference Citation Analysis]
16 Wu L, Xie X, Liang T, Ma J, Yang L, Yang J, Li L, Xi Y, Li H, Zhang J, Chen X, Ding Y, Wu Q. Integrated Multi-Omics for Novel Aging Biomarkers and Antiaging Targets. Biomolecules 2022;12:39. [DOI: 10.3390/biom12010039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
17 Cai JL, Li XP, Zhu YL, Yi GQ, Wang W, Chen XY, Deng GM, Yang L, Cai HZ, Tong QZ, Zhou L, Tian M, Xia XH, Liu PA. Polygonatum sibiricum polysaccharides (PSP) improve the palmitic acid (PA)-induced inhibition of survival, inflammation, and glucose uptake in skeletal muscle cells. Bioengineered 2021;12:10147-59. [PMID: 34872451 DOI: 10.1080/21655979.2021.2001184] [Reference Citation Analysis]
18 Carlson AP, Mckay W, Edwards JS, Swaminathan R, Santacruz KS, Mims RL, Yonas H, Roitbak T. MicroRNA Analysis of Human Stroke Brain Tissue Resected during Decompressive Craniectomy/Stroke-Ectomy Surgery. Genes 2021;12:1860. [DOI: 10.3390/genes12121860] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
19 Wong LM, Phoon LQ, Wei LK. Epigenetics Modifications in Large-Artery Atherosclerosis: A Systematic Review. J Stroke Cerebrovasc Dis 2021;30:106033. [PMID: 34598837 DOI: 10.1016/j.jstrokecerebrovasdis.2021.106033] [Reference Citation Analysis]
20 Chen Z, Fan T, Zhao X, Zhang Z. Depleting SOX2 improves ischemic stroke via lncRNA PVT1/microRNA-24-3p/STAT3 axis. Mol Med 2021;27:107. [PMID: 34521353 DOI: 10.1186/s10020-021-00346-8] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
21 Stopic B, Dragicevic S, Medic-Brkic B, Nikolic A, Stojanovic M, Budisavljevic S, Dimkovic N. Biomarkers of Uremic Cardiotoxicity. Toxins (Basel) 2021;13:639. [PMID: 34564643 DOI: 10.3390/toxins13090639] [Reference Citation Analysis]
22 Feng B, Meng X, Zhou H, Chen L, Zou C, Liang L, Meng Y, Xu N, Wang H, Zou D. Identification of Dysregulated Mechanisms and Potential Biomarkers in Ischemic Stroke Onset. Int J Gen Med 2021;14:4731-44. [PMID: 34456585 DOI: 10.2147/IJGM.S327594] [Reference Citation Analysis]
23 Huang Y, Wang Y, Liu X, Ouyang Y. Silencing lncRNA HOTAIR improves the recovery of neurological function in ischemic stroke via the miR-148a-3p/KLF6 axis. Brain Res Bull 2021;176:43-53. [PMID: 34391823 DOI: 10.1016/j.brainresbull.2021.08.003] [Reference Citation Analysis]
24 Liyanage T, Lai M, Slaughter G. Label-free tapered optical fiber plasmonic biosensor. Anal Chim Acta 2021;1169:338629. [PMID: 34088366 DOI: 10.1016/j.aca.2021.338629] [Reference Citation Analysis]
25 Zhou H, Huang L, Liang L, Chen L, Zou C, Li Z, Li R, Jian C, Zou D. Identification of an miRNA Regulatory Network and Candidate Markers for Ischemic Stroke Related to Diabetes. Int J Gen Med 2021;14:3213-23. [PMID: 34262334 DOI: 10.2147/IJGM.S319503] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Alhazzani A, Venkatachalapathy P, Padhilahouse S, Sellappan M, Munisamy M, Sekaran M, Kumar A. Biomarkers for Antiplatelet Therapies in Acute Ischemic Stroke: A Clinical Review. Front Neurol 2021;12:667234. [PMID: 34177775 DOI: 10.3389/fneur.2021.667234] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
27 Vijayan M, Reddy PH. Non-Coding RNAs Based Molecular Links in Type 2 Diabetes, Ischemic Stroke, and Vascular Dementia. J Alzheimers Dis 2020;75:353-83. [PMID: 32310177 DOI: 10.3233/JAD-200070] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 14.0] [Reference Citation Analysis]
28 Adly Sadik N, Ahmed Rashed L, Ahmed Abd-El Mawla M. Circulating miR-155 and JAK2/STAT3 Axis in Acute Ischemic Stroke Patients and Its Relation to Post-Ischemic Inflammation and Associated Ischemic Stroke Risk Factors. Int J Gen Med 2021;14:1469-84. [PMID: 33911894 DOI: 10.2147/IJGM.S295939] [Reference Citation Analysis]
29 Deng L, Guo Y, Liu J, Wang X, Chen S, Wang Q, Rao J, Wang Y, Zuo T, Hu Q, Zhao X, Dong Z. miR-671-5p Attenuates Neuroinflammation via Suppressing NF-κB Expression in an Acute Ischemic Stroke Model. Neurochem Res 2021;46:1801-13. [PMID: 33871800 DOI: 10.1007/s11064-021-03321-1] [Reference Citation Analysis]
30 Czajka P, Fitas A, Jakubik D, Eyileten C, Gasecka A, Wicik Z, Siller-Matula JM, Filipiak KJ, Postula M. MicroRNA as Potential Biomarkers of Platelet Function on Antiplatelet Therapy: A Review. Front Physiol 2021;12:652579. [PMID: 33935804 DOI: 10.3389/fphys.2021.652579] [Cited by in Crossref: 1] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
31 Chavda V, Madhwani K. Coding and non-coding nucleotides': The future of stroke gene therapeutics. Genomics 2021;113:1291-307. [PMID: 33677059 DOI: 10.1016/j.ygeno.2021.03.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Jakubik D, Fitas A, Eyileten C, Jarosz-Popek J, Nowak A, Czajka P, Wicik Z, Sourij H, Siller-Matula JM, De Rosa S, Postula M. MicroRNAs and long non-coding RNAs in the pathophysiological processes of diabetic cardiomyopathy: emerging biomarkers and potential therapeutics. Cardiovasc Diabetol 2021;20:55. [PMID: 33639953 DOI: 10.1186/s12933-021-01245-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
33 Langlo KAR, Silva GJJ, Overrein TS, Adams V, Wisløff U, Dalen H, Rolim N, Hallan SI. Circulating microRNAs May Serve as Biomarkers for Hypertensive Emergency End-Organ Injuries and Address Underlying Pathways in an Animal Model. Front Cardiovasc Med 2020;7:626699. [PMID: 33644125 DOI: 10.3389/fcvm.2020.626699] [Reference Citation Analysis]
34 Filippenkov IB, Dergunova LV, Limborska SA, Myasoedov NF. Neuroprotective Effects of Peptides in the Brain: Transcriptome Approach. Biochemistry (Mosc) 2020;85:279-87. [PMID: 32564732 DOI: 10.1134/S0006297920030037] [Reference Citation Analysis]
35 Chen TH. Circulating microRNAs as potential biomarkers and therapeutic targets in spinal muscular atrophy. Ther Adv Neurol Disord 2020;13:1756286420979954. [PMID: 33488772 DOI: 10.1177/1756286420979954] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
36 Saini V, Dawar R, Suneja S, Gangopadhyay S, Kaur C. Can microRNA become next-generation tools in molecular diagnostics and therapeutics? A systematic review. Egypt J Med Hum Genet 2021;22. [DOI: 10.1186/s43042-020-00125-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
37 Wu Y, Li Q, Zhang R, Dai X, Chen W, Xing D. Circulating microRNAs: Biomarkers of disease. Clin Chim Acta 2021;516:46-54. [PMID: 33485903 DOI: 10.1016/j.cca.2021.01.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
38 Singh S, de Ronde MWJ, Creemers EE, Van der Made I, Meijering R, Chan MY, Hwee Tan S, Tang Chin C, Mark Richards A, Troughton RW, Yean Yip Fong A, Yan BP, Pinto-Sietsma SJ. Low miR-19b-1-5p Expression Is Related to Aspirin Resistance and Major Adverse Cardio- Cerebrovascular Events in Patients With Acute Coronary Syndrome. J Am Heart Assoc 2021;10:e017120. [PMID: 33441016 DOI: 10.1161/JAHA.120.017120] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
39 Zhou L, Yang W, Yao E, Li H, Wang J, Wang K, Zhong X, Peng Z, Huang X. MicroRNA-488-3p Regulates Neuronal Cell Death in Cerebral Ischemic Stroke Through Vacuolar Protein Sorting 4B (VPS4B). Neuropsychiatr Dis Treat 2021;17:41-55. [PMID: 33442254 DOI: 10.2147/NDT.S255666] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
40 Ma Q, Dasgupta C, Shen G, Li Y, Zhang L. MicroRNA-210 downregulates TET2 and contributes to inflammatory response in neonatal hypoxic-ischemic brain injury. J Neuroinflammation 2021;18:6. [PMID: 33402183 DOI: 10.1186/s12974-020-02068-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
41 Martucci G, Arcadipane A, Tuzzolino F, Occhipinti G, Panarello G, Carcione C, Bonicolini E, Vitiello C, Lorusso R, Conaldi PG, Miceli V. Identification of a Circulating miRNA Signature to Stratify Acute Respiratory Distress Syndrome Patients. J Pers Med 2020;11:15. [PMID: 33375484 DOI: 10.3390/jpm11010015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
42 Kadir RRA, Alwjwaj M, Bayraktutan U. MicroRNA: An Emerging Predictive, Diagnostic, Prognostic and Therapeutic Strategy in Ischaemic Stroke. Cell Mol Neurobiol. [DOI: 10.1007/s10571-020-01028-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
43 Jarosz-Popek J, Wolska M, Gasecka A, Czajka P, Jakubik D, Sharif L, Adem T, Liu WL, Mirowska-Guzel D, Postula M, Eyileten C. The Importance of Non-Coding RNAs in Neurodegenerative Processes of Diabetes-Related Molecular Pathways. J Clin Med 2020;10:E9. [PMID: 33374507 DOI: 10.3390/jcm10010009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
44 Rivero-Segura NA, Bello-Chavolla OY, Barrera-Vázquez OS, Gutierrez-Robledo LM, Gomez-Verjan JC. Promising biomarkers of human aging: In search of a multi-omics panel to understand the aging process from a multidimensional perspective. Ageing Res Rev 2020;64:101164. [PMID: 32977058 DOI: 10.1016/j.arr.2020.101164] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 9.5] [Reference Citation Analysis]
45 Wuu YR, Hu B, Okunola H, Paul AM, Blaber EA, Cheng-Campbell M, Beheshti A, Grabham P. LET-Dependent Low Dose and Synergistic Inhibition of Human Angiogenesis by Charged Particles: Validation of miRNAs that Drive Inhibition. iScience 2020;23:101771. [PMID: 33376971 DOI: 10.1016/j.isci.2020.101771] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
46 Ryu CS, Oh SH, Lee KO, Park HS, An HJ, Lee JY, Ko EJ, Park HW, Kim OJ, Kim NK. MiR-10a, 27a, 34b/c, and 300 Polymorphisms are Associated with Ischemic Stroke Susceptibility and Post-Stroke Mortality. Life (Basel) 2020;10:E309. [PMID: 33255549 DOI: 10.3390/life10120309] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
47 Wicik Z, Eyileten C, Jakubik D, Simões SN, Martins DC Jr, Pavão R, Siller-Matula JM, Postula M. ACE2 Interaction Networks in COVID-19: A Physiological Framework for Prediction of Outcome in Patients with Cardiovascular Risk Factors. J Clin Med 2020;9:E3743. [PMID: 33233425 DOI: 10.3390/jcm9113743] [Cited by in Crossref: 10] [Cited by in F6Publishing: 33] [Article Influence: 5.0] [Reference Citation Analysis]
48 Ling Y, Gong T, Zhang J, Gu Q, Gao X, Weng X, Liu J, Sun J. Gut Microbiome Signatures Are Biomarkers for Cognitive Impairment in Patients With Ischemic Stroke. Front Aging Neurosci 2020;12:511562. [PMID: 33192448 DOI: 10.3389/fnagi.2020.511562] [Cited by in Crossref: 5] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
49 Giordano M, Trotta MC, Ciarambino T, D'Amico M, Galdiero M, Schettini F, Paternosto D, Salzillo M, Alfano R, Andreone V, Malatino LS, Biolo G, Paolisso G, Adinolfi LE. Circulating MiRNA-195-5p and -451a in Diabetic Patients with Transient and Acute Ischemic Stroke in the Emergency Department. Int J Mol Sci. 2020;21. [PMID: 33076256 DOI: 10.3390/ijms21207615] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
50 Lu Y, Han Y, He J, Zhou B, Fang P, Li X. LncRNA FOXD3-AS1 knockdown protects against cerebral ischemia/reperfusion injury via miR-765/BCL2L13 axis. Biomed Pharmacother 2020;132:110778. [PMID: 33068927 DOI: 10.1016/j.biopha.2020.110778] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
51 Eyileten C, Sharif L, Wicik Z, Jakubik D, Jarosz-Popek J, Soplinska A, Postula M, Czlonkowska A, Kaplon-Cieslicka A, Mirowska-Guzel D. The Relation of the Brain-Derived Neurotrophic Factor with MicroRNAs in Neurodegenerative Diseases and Ischemic Stroke. Mol Neurobiol 2021;58:329-47. [PMID: 32944919 DOI: 10.1007/s12035-020-02101-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
52 Zareba L, Fitas A, Wolska M, Junger E, Eyileten C, Wicik Z, De Rosa S, Siller-Matula JM, Postula M. MicroRNAs and Long Noncoding RNAs in Coronary Artery Disease: New and Potential Therapeutic Targets. Cardiol Clin 2020;38:601-17. [PMID: 33036721 DOI: 10.1016/j.ccl.2020.07.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
53 Bulygin KV, Beeraka NM, Saitgareeva AR, Nikolenko VN, Gareev I, Beylerli O, Akhmadeeva LR, Mikhaleva LM, Torres Solis LF, Solís Herrera A, Avila-Rodriguez MF, Somasundaram SG, Kirkland CE, Aliev G. Can miRNAs Be Considered as Diagnostic and Therapeutic Molecules in Ischemic Stroke Pathogenesis?-Current Status. Int J Mol Sci 2020;21:E6728. [PMID: 32937836 DOI: 10.3390/ijms21186728] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
54 Qian Y, Chopp M, Chen J. Emerging role of microRNAs in ischemic stroke with comorbidities. Experimental Neurology 2020;331:113382. [DOI: 10.1016/j.expneurol.2020.113382] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
55 Gasecka A, Siwik D, Gajewska M, Jaguszewski MJ, Mazurek T, Filipiak KJ, Postuła M, Eyileten C. Early Biomarkers of Neurodegenerative and Neurovascular Disorders in Diabetes. J Clin Med 2020;9:E2807. [PMID: 32872672 DOI: 10.3390/jcm9092807] [Cited by in Crossref: 9] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
56 Feng Y, Kang K, Xue Q, Chen Y, Wang W, Cao J. Value of plasma homocysteine to predict stroke, cardiovascular diseases, and new-onset hypertension: A retrospective cohort study. Medicine (Baltimore) 2020;99:e21541. [PMID: 32846763 DOI: 10.1097/MD.0000000000021541] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
57 Rzemieniec J, Bratek E, Wnuk A, Przepiórska K, Salińska E, Kajta M. Neuroprotective effect of 3,3'-Diindolylmethane against perinatal asphyxia involves inhibition of the AhR and NMDA signaling and hypermethylation of specific genes. Apoptosis 2020;25:747-62. [PMID: 32816128 DOI: 10.1007/s10495-020-01631-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
58 Zhang T, Tian C, Wu J, Zhang Y, Wang J, Kong Q, Mu L, Sun B, Ai T, Wang Y, Zhao W, Wang D, Li H, Wang G. MicroRNA-182 exacerbates blood-brain barrier (BBB) disruption by downregulating the mTOR/FOXO1 pathway in cerebral ischemia. FASEB J 2020;34:13762-75. [PMID: 32808351 DOI: 10.1096/fj.201903092R] [Cited by in Crossref: 6] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
59 Chen SD, Pan HY, Huang JB, Liu XP, Li JH, Ho CJ, Tsai MH, Yang JL, Chen SF, Chen NC, Chuang YC. Circulating MicroRNAs from Serum Exosomes May Serve as a Putative Biomarker in the Diagnosis and Treatment of Patients with Focal Cortical Dysplasia. Cells 2020;9:E1867. [PMID: 32785072 DOI: 10.3390/cells9081867] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
60 Valtorta S, Salvatore D, Rainone P, Belloli S, Bertoli G, Moresco RM. Molecular and Cellular Complexity of Glioma. Focus on Tumour Microenvironment and the Use of Molecular and Imaging Biomarkers to Overcome Treatment Resistance. Int J Mol Sci 2020;21:E5631. [PMID: 32781585 DOI: 10.3390/ijms21165631] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
61 Ismael S, Moshahid Khan M, Kumar P, Kodidela S, Mirzahosseini G, Kumar S, Ishrat T. HIV Associated Risk Factors for Ischemic Stroke and Future Perspectives. Int J Mol Sci 2020;21:E5306. [PMID: 32722629 DOI: 10.3390/ijms21155306] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
62 Dergunova LV, Filippenkov IB, Limborska SA, Myasoedov NF. Pharmacotranscriptomics of peptide drugs with neuroprotective properties. Med Res Rev 2021;41:754-69. [PMID: 32638434 DOI: 10.1002/med.21704] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
63 Xie K, Cai Y, Yang P, Du F, Wu K. Upregulating microRNA-874-3p inhibits CXCL12 expression to promote angiogenesis and suppress inflammatory response in ischemic stroke. Am J Physiol Cell Physiol 2020;319:C579-88. [PMID: 32608990 DOI: 10.1152/ajpcell.00001.2020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
64 Chi NF, Chiou HY, Chou SY, Hu CJ, Chen KY, Chang CF, Hsieh YC. Hyperglycemia-related FAS gene and hsa-let-7b-5p as markers of poor outcomes for ischaemic stroke. Eur J Neurol 2020;27:1647-55. [PMID: 32352616 DOI: 10.1111/ene.14288] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
65 Hadj-moussa H, Storey KB. The OxymiR response to oxygen limitation: a comparative microRNA perspective. Journal of Experimental Biology 2020;223:jeb204594. [DOI: 10.1242/jeb.204594] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
66 Li L, Lou W, Li H, Zhu Y, Huang X. Upregulated C-C Motif Chemokine Ligand 2 Promotes Ischemic Stroke via Chemokine Signaling Pathway. Ann Vasc Surg 2020;68:476-86. [PMID: 32422289 DOI: 10.1016/j.avsg.2020.04.047] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
67 Chai Z, Gong J, Zheng P, Zheng J. Inhibition of miR-19a-3p decreases cerebral ischemia/reperfusion injury by targeting IGFBP3 in vivo and in vitro. Biol Res 2020;53:17. [PMID: 32312329 DOI: 10.1186/s40659-020-00280-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 29] [Article Influence: 7.0] [Reference Citation Analysis]
68 Yang XL, Cao CZ, Zhang QX. MiR-195 alleviates oxygen-glucose deprivation/reperfusion-induced cell apoptosis via inhibition of IKKα-mediated NF-κB pathway. Int J Neurosci 2021;131:755-64. [PMID: 32271641 DOI: 10.1080/00207454.2020.1754212] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
69 Zhang YF, Meng LB, Hao ML, Yang JF, Zou T. Identification of Co-expressed Genes Between Atrial Fibrillation and Stroke. Front Neurol 2020;11:184. [PMID: 32265825 DOI: 10.3389/fneur.2020.00184] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
70 Jafarzadeh-Esfehani R, Mostafa Parizadeh S, Sabeti Aghabozorgi A, Yavari N, Sadr-Nabavi A, Alireza Parizadeh S, Ghandehari M, Javanbakht A, Rezaei-Kalat A, Mahdi Hassanian S, Vojdanparast M, Ferns GA, Khazaei M, Avan A. Circulating and tissue microRNAs as a potential diagnostic biomarker in patients with thrombotic events. J Cell Physiol 2020;235:6393-403. [PMID: 32198752 DOI: 10.1002/jcp.29639] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
71 Mu J, Cheng X, Zhong S, Chen X, Zhao C. Neuroprotective effects of miR-532-5p against ischemic stroke. Metab Brain Dis 2020;35:753-63. [PMID: 32086725 DOI: 10.1007/s11011-020-00544-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
72 Kalani MYS, Alsop E, Meechoovet B, Beecroft T, Agrawal K, Whitsett TG, Huentelman MJ, Spetzler RF, Nakaji P, Kim S, Van Keuren-Jensen K. Extracellular microRNAs in blood differentiate between ischaemic and haemorrhagic stroke subtypes. J Extracell Vesicles 2020;9:1713540. [PMID: 32128071 DOI: 10.1080/20013078.2020.1713540] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
73 Stanzione R, Cotugno M, Bianchi F, Marchitti S, Forte M, Volpe M, Rubattu S. Pathogenesis of Ischemic Stroke: Role of Epigenetic Mechanisms. Genes (Basel) 2020;11:E89. [PMID: 31941075 DOI: 10.3390/genes11010089] [Cited by in Crossref: 12] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]
74 Atherton LJ, Jorquera PA, Bakre AA, Tripp RA. Determining Immune and miRNA Biomarkers Related to Respiratory Syncytial Virus (RSV) Vaccine Types. Front Immunol 2019;10:2323. [PMID: 31649663 DOI: 10.3389/fimmu.2019.02323] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
75 Sabatino J, Wicik Z, De Rosa S, Eyileten C, Jakubik D, Spaccarotella C, Mongiardo A, Postula M, Indolfi C. MicroRNAs fingerprint of bicuspid aortic valve. Journal of Molecular and Cellular Cardiology 2019;134:98-106. [DOI: 10.1016/j.yjmcc.2019.07.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
76 Pordzik J, Jakubik D, Jarosz-Popek J, Wicik Z, Eyileten C, De Rosa S, Indolfi C, Siller-Matula JM, Czajka P, Postula M. Significance of circulating microRNAs in diabetes mellitus type 2 and platelet reactivity: bioinformatic analysis and review. Cardiovasc Diabetol. 2019;18:113. [PMID: 31470851 DOI: 10.1186/s12933-019-0918-x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 65] [Article Influence: 13.0] [Reference Citation Analysis]
77 Nies H, Zakaria Z, Mohamad M, Chan W, Zaki N, Sinnott R, Napis S, Chamoso P, Omatu S, Corchado J. A Review of Computational Methods for Clustering Genes with Similar Biological Functions. Processes 2019;7:550. [DOI: 10.3390/pr7090550] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
78 Ma Q, Zhang L, Pearce WJ. MicroRNAs in brain development and cerebrovascular pathophysiology. Am J Physiol Cell Physiol 2019;317:C3-C19. [PMID: 30840494 DOI: 10.1152/ajpcell.00022.2019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]